June 25, 2011 – In the Health section of today’s edition of the New York Times, columnist Barry Meier points out that Americans’ “impulse to covet the new and improved” may be at the root of the DePuy Hip Recall. (“In Medicine, New Isn’t Always Improved”) While stopping far short of blaming the patients themselves for…
The once trusted and highly respected Johnson & Johnson name has taken some major image hits in the last 15 months according to a recent article. During this time, the $60 Billion company has voluntarily recalled over 50 products. In its cover story, Johnson & Johnson’s Quality Catastrophe, Bloomberg/ Businessweek highlights a number of the products…
As reported today on Bloomberg.com, the British Orthopaedic Association and the British Hip Society issued a statement that the failure rate of the DePuy ASR XL Acetabular System is more than twice what was originally represented when the device was recalled in 2010. According to the article, nearly half of all patients who received the recalled device require…
And Why This Matters to Me Less than a year ago, I underwent bilateral total hip replacement surgery. It was one trip to the doctor’s I would have sooner avoided. But I had no choice and the surgery, fortunately, appears to have been successful. Then, just a few months out of the operating room, I learned of a…
Much is being written about the worldwide recall of ASR hip implants manufactured by DePuy Companies, a division of Johnson & Johnson. According to attorneys at Walkup, Melodia, Kelly & Schoenberger, who filed the first DePuy ASR products liability lawsuit in the country, the manufacturers knew of the defect long before it recalled the device in August of…